BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18418656)

  • 21. Complete pathologic response after preoperative rectal cancer chemoradiotherapy.
    Ciccocioppo A; Stephens JH; Hewett PJ; Rieger NA
    ANZ J Surg; 2009 Jun; 79(6):481-4. PubMed ID: 19566874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of volumetric analysis, histopathologic downstaging, and tumor regression grade in evaluating tumor response in locally advanced rectal cancer following preoperative chemoradiation.
    Kim NK; Baik SH; Min BS; Pyo HR; Choi YJ; Kim H; Seong J; Keum KC; Rha SY; Chung HC
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):204-10. PubMed ID: 17084555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery.
    Park JW; Lim SB; Kim DY; Jung KH; Hong YS; Chang HJ; Choi HS; Jeong SY
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):810-7. PubMed ID: 19101093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer.
    Kim YH; Kim DY; Kim TH; Jung KH; Chang HJ; Jeong SY; Sohn DK; Choi HS; Ahn JB; Kim DH; Lim SB; Lee JS; Park JG
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):761-8. PubMed ID: 15936557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of cyclooxygenase-2 protein expression is a predictor of tumor regression in rectal cancer treated with preoperative short-term chemoradiotherapy.
    Kobayashi H; Hashiguchi Y; Ueno H; Shinto E; Kajiwara Y; Mochizuki H
    Dis Colon Rectum; 2007 Sep; 50(9):1354-62. PubMed ID: 17308999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance imaging in rectal cancer downstaged using neoadjuvant chemoradiation: accuracy of prediction of tumour stage and circumferential resection margin status.
    Kulkarni T; Gollins S; Maw A; Hobson P; Byrne R; Widdowson D
    Colorectal Dis; 2008 Jun; 10(5):479-89. PubMed ID: 18318754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil or 5-fluorouracil and oxaliplatin on outcomes in rectal cancer.
    Dolinsky CM; Mahmoud NN; Mick R; Sun W; Whittington RW; Solin LJ; Haller DG; Giantonio BJ; O'Dwyer PJ; Rosato EF; Fry RD; Metz JM
    J Surg Oncol; 2007 Sep; 96(3):207-12. PubMed ID: 17443718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of radiotherapy on different histopathological types of rectal carcinoma.
    Sengul N; Wexner SD; Woodhouse S; Arrigain S; Xu M; Larach JA; Ahn BK; Weiss EG; Nogueras JJ; Berho M
    Colorectal Dis; 2006 May; 8(4):283-8. PubMed ID: 16630231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation.
    Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Saltz LB; Goodman KA; Minsky BD; Wong WD; Weiser MR
    Cancer; 2008 Jul; 113(1):57-64. PubMed ID: 18442099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
    Drebber U; Lay M; Wedemeyer I; Vallböhmer D; Bollschweiler E; Brabender J; Mönig SP; Hölscher AH; Dienes HP; Odenthal M
    Int J Oncol; 2011 Aug; 39(2):409-15. PubMed ID: 21567082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience.
    Valentini V; Coco C; Rizzo G; Manno A; Crucitti A; Mattana C; Ratto C; Verbo A; Vecchio FM; Barbaro B; Gambacorta MA; Montoro C; Barba MC; Sofo L; Papa V; Menghi R; D'Ugo DM; Doglietto G
    Surgery; 2009 May; 145(5):486-94. PubMed ID: 19375606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complete response after neoadjuvant therapy in rectal cancer: to operate or not to operate?
    Dedemadi G; Wexner SD
    Dig Dis; 2012; 30 Suppl 2():109-17. PubMed ID: 23207942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation.
    Oberholzer K; Menig M; Kreft A; Schneider A; Junginger T; Heintz A; Kreitner KF; Hötker AM; Hansen T; Düber C; Schmidberger H
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):842-8. PubMed ID: 21236593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laparoscopic total mesorectal excision after neoadjuvant chemoradiotherapy.
    Rosati R; Bona S; Romario UF; Elmore U; Furlan N
    Surg Oncol; 2007 Dec; 16 Suppl 1():S83-9. PubMed ID: 18042378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted.
    Guillem JG; Díaz-González JA; Minsky BD; Valentini V; Jeong SY; Rodriguez-Bigas MA; Coco C; Leon R; Hernandez-Lizoain JL; Aristu JJ; Riedel ER; Nitti D; Wong WD; Pucciarelli S
    J Clin Oncol; 2008 Jan; 26(3):368-73. PubMed ID: 18202411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-level downstaging and complete pathologic response after preoperative long-term radiochemotherapy for locally advanced rectal cancer.
    Jonas J; Moroni E; Cavallaro A; Colasanti M; Sautter-Bihl ML; Frenzel H; Lohe B; Bähr R
    G Chir; 2007 Mar; 28(3):65-71. PubMed ID: 17419902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
    Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
    Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preoperative chemoradiotherapy with S-1 for advanced low rectal cancer].
    Kitani K; Okajima K; Sato K; Isono S; Kimura H; Ikeda M; Inoue K; Iwama M; Tsujie M; Nakayama T; Fujiwara Y; Murata M; Yukawa M; Ota Y; Inoue M
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2122-4. PubMed ID: 22202303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical complications and pathologic complete response after neoadjuvant chemoradiation in locally advanced rectal cancer.
    Duldulao MP; Lee W; Le M; Wiatrek R; Nelson RA; Chen Z; Li W; Kim J; Garcia-Aguilar J
    Am Surg; 2011 Oct; 77(10):1281-5. PubMed ID: 22127070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.